Direct-acting oral anticoagulant use at extremes of body weight: literature review and recommendations

K Covert, DL Branam - American Journal of Health-System …, 2020 - academic.oup.com
Purpose To review the literature on treatment of venous thromboembolism (VTE) and
prevention of cardioembolic stroke with direct-acting oral anticoagulants (DOACs) in low …

Direct-acting oral anticoagulant use at extremes of body weight: Literature review and recommendations

K Covert, DL Branam - … journal of the American Society of …, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose To review the literature on treatment of venous thromboembolism (VTE) and
prevention of cardioembolic stroke with direct-acting oral anticoagulants (DOACs) in low …

Direct-acting oral anticoagulant use at extremes of body weight: Literature review and recommendations.

K Covert, DL Branam - … Journal of Health-system Pharmacy: AJHP …, 2020 - europepmc.org
Purpose To review the literature on treatment of venous thromboembolism (VTE) and
prevention of cardioembolic stroke with direct-acting oral anticoagulants (DOACs) in low …

Direct-Acting Oral Anticoagulant Use at Extremes of Body Weight: Literature Review and Recommendations

K Covert, DL Branam - American Journal of Health-System Pharmacy, 2020 - dc.etsu.edu
To review the literature on treatment of venous thromboembolism (VTE) and prevention of
cardioembolic stroke with direct-acting oral anticoagulants (DOACs) in low-and high-body …

[PDF][PDF] Direct-acting oral anticoagulant use at extremes of body weight: Literature review and recommendations

TN Home - Am J Health-Syst Pharm, 2020 - binasss.sa.cr
Purpose. To review the literature on treatment of venous thromboembolism (VTE) and
prevention of cardioembolic stroke with direct-acting oral anticoagulants (DOACs) in low …

Direct-acting oral anticoagulant use at extremes of body weight: Literature review and recommendations.

K Covert, DL Branam - American Journal of Health-System …, 2020 - search.ebscohost.com
Purpose To review the literature on treatment of venous thromboembolism (VTE) and
prevention of cardioembolic stroke with direct-acting oral anticoagulants (DOACs) in low …